Cargando…
LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylati...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000741/ https://www.ncbi.nlm.nih.gov/pubmed/36899941 http://dx.doi.org/10.3390/cells12050805 |
_version_ | 1784903954674483200 |
---|---|
author | Villalonga, Elodie Mosrin, Christine Normand, Thierry Girardin, Caroline Serrano, Amandine Žunar, Bojan Doudeau, Michel Godin, Fabienne Bénédetti, Hélène Vallée, Béatrice |
author_facet | Villalonga, Elodie Mosrin, Christine Normand, Thierry Girardin, Caroline Serrano, Amandine Žunar, Bojan Doudeau, Michel Godin, Fabienne Bénédetti, Hélène Vallée, Béatrice |
author_sort | Villalonga, Elodie |
collection | PubMed |
description | LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylation of cofilin, an actin depolymerising factor. Thus, they are involved in many biological processes, such as cell cycle, cell migration, and neuronal differentiation. Consequently, they are also part of numerous pathological mechanisms, especially in cancer, where their involvement has been reported for a few years and has led to the development of a wide range of inhibitors. LIMK1 and LIMK2 are known to be part of the Rho family GTPase signal transduction pathways, but many more partners have been discovered over the decades, and both LIMKs are suspected to be part of an extended and various range of regulation pathways. In this review, we propose to consider the different molecular mechanisms involving LIM kinases and their associated signalling pathways, and to offer a better understanding of their variety of actions within the physiology and physiopathology of the cell. |
format | Online Article Text |
id | pubmed-10000741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100007412023-03-11 LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features Villalonga, Elodie Mosrin, Christine Normand, Thierry Girardin, Caroline Serrano, Amandine Žunar, Bojan Doudeau, Michel Godin, Fabienne Bénédetti, Hélène Vallée, Béatrice Cells Review LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) are serine/threonine and tyrosine kinases and the only two members of the LIM kinase family. They play a crucial role in the regulation of cytoskeleton dynamics by controlling actin filaments and microtubule turnover, especially through the phosphorylation of cofilin, an actin depolymerising factor. Thus, they are involved in many biological processes, such as cell cycle, cell migration, and neuronal differentiation. Consequently, they are also part of numerous pathological mechanisms, especially in cancer, where their involvement has been reported for a few years and has led to the development of a wide range of inhibitors. LIMK1 and LIMK2 are known to be part of the Rho family GTPase signal transduction pathways, but many more partners have been discovered over the decades, and both LIMKs are suspected to be part of an extended and various range of regulation pathways. In this review, we propose to consider the different molecular mechanisms involving LIM kinases and their associated signalling pathways, and to offer a better understanding of their variety of actions within the physiology and physiopathology of the cell. MDPI 2023-03-04 /pmc/articles/PMC10000741/ /pubmed/36899941 http://dx.doi.org/10.3390/cells12050805 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Villalonga, Elodie Mosrin, Christine Normand, Thierry Girardin, Caroline Serrano, Amandine Žunar, Bojan Doudeau, Michel Godin, Fabienne Bénédetti, Hélène Vallée, Béatrice LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title | LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title_full | LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title_fullStr | LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title_full_unstemmed | LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title_short | LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features |
title_sort | lim kinases, limk1 and limk2, are crucial node actors of the cell fate: molecular to pathological features |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000741/ https://www.ncbi.nlm.nih.gov/pubmed/36899941 http://dx.doi.org/10.3390/cells12050805 |
work_keys_str_mv | AT villalongaelodie limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT mosrinchristine limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT normandthierry limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT girardincaroline limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT serranoamandine limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT zunarbojan limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT doudeaumichel limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT godinfabienne limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT benedettihelene limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures AT valleebeatrice limkinaseslimk1andlimk2arecrucialnodeactorsofthecellfatemoleculartopathologicalfeatures |